Drug Discovery

Cell therapy
#DDW Turning Science into Business Symposium #Drug discovery #Events

Watch DDW Symposium at Francis Crick Institute on-demand

If you missed the DDW Turning Science into Business Symposium, which took place at the Francis Crick Institute, London, UK on 4 November 2025, you can now watch it on-demand here.  This free half day event featured:  six in-depth presentations from industry experts… Read More

#News

#Artificial intelligence (AI) #Automation / robotics #Drug discovery

Standardising organoid workflows: How automation and AI enable reliable, scalable models – custom webinar with Galatek Nov 2025

Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow challenges, from culture variability to labour-intensive handling. In this webinar, hosted by DDW and supported by Galatek, we will explore the evolving landscape of organoid research,… Read More

#Webinars

AI clinical trials concept
#Artificial intelligence (AI) #Automation #Drug discovery #Webinar

Webinar: Harness AI in ways that drive measurable R&D impact

AI has reached a turning point in biotech. Real-world scientific agents are beginning to automate the repetitive tasks that slow down research, and transform how we think about extracting insights from scientific data. In this webinar on… Read More

Webinar date:
Supported by Benchling
#News

Neuronal network
#Drug discovery #eBook #Neurodegenerative disorders #Neuroscience #Psychiatry

eBook: What’s new in neuroscience drug discovery?

The global neuroscience market has grown significantly in the last 10 years, driven predominantly by an ageing population and increasing cases of neurodegenerative diseases like Alzheimer’s disease (AD). The neuroscience market size was estimated at $44.65 billion in 2023 and is projected to reach $65.22 billion by 2030,… Read More

#News

#Automation / robotics #Events #Lab technology #SLAS2026

Register your interest for DDW track at SLAS2026

For the third year running DDW is organising a series of seminars at SLAS International Conference and Exhibition. Based on the SLAS2026 theme of Catalyze Discovery, these will be available to visitors of SLAS2026 (7-11 February 2026, Boston, USA). This programme, Creating Cures: The role of lab… Read More

#News

#Drug discovery

Ebook: What’s new in neuroscience drug discovery?

Some of the most significant advances in neuroscience in 2025 have been in gene therapies. Particularly groundbreaking were the results of a global clinical trial of AMT-130, the first gene therapy to be tested in people with Huntington’s, which convincingly slowed progression of the disease. This eBook, sponsored by Emulate,… Read More

#DDW eBooks

CAR-T cells attacking a cancer cell
#DDW Turning Science into Business Symposium #Drug discovery #Events

DDW Turning Science into Business Symposium available on-demand

The on-demand version of the DDW Turning Science into Business Symposium is available to watch now!  The event, which took place at The Francis Crick Institute on 4 November, features talks covering aspects of drug discovery including AI, oncology, CRISPR, neuroscience and more.  It… Read More

#Editor's Choice #News

#Artificial intelligence (AI) #Automation #Drug discovery #Webinar

How AI agents and scientific models are accelerating biotech innovation

AI has reached a turning point in biotech. Real-world scientific agents are beginning to automate the repetitive tasks that slow down research, and transform how we think about extracting insights from scientific data. In this webinar on… Read More

Webinar date:
Supported by Benchling
#News

#AI / data analytics / healthtech / informatics #Automation #Drug discovery #Organoids #Webinar

Webinar: Overcome organoid workflow challenges with AI

Hosted by Drug Discovery World and supported by Galatek, this webinar explores how automation and AI enable reliable, scalable models by standardising organoid workflows. Organoids have emerged as powerful in vitro models in disease modelling, drug screening, and regenerative medicine, but their complexity introduces major workflow… Read More

Webinar date:
Supported by Galatek
#News

eBook
#Book review #Collaborative Drug Discovery (CDD) #Drug discovery

Book review: ‘Inside CDD Vault’

Diana Turner reviews ‘Inside CDD Vault – Behind the code: The human side of Collaborative Drug discovery’. Collaborative Drug Discovery’s new book is designed to provide a personal insight into the company, its mission, and the people behind the product. As the Foreward states: “CDD is a rare… Read More

#Business & Investment #Exclusive Content

Deal making concept
#Biomarkers #Biotechnology #Drug development

Mursla Bio partners with pharma company on drug development 

Biotechnology company Mursla Bio has announced a partnership with a pharma company to advance biomarker-guided drug development.  While the company has not been named, Mursla Bio says it is a global pharma leader recognised for its expertise in biomarker-guided precision medicine in metabolic dysfunction-associated steatohepatitis (MASH). … Read More

#Business & Investment #News

People working in an office
#Biopharma #Business #Drug discovery #Product launch

New platform hopes to solve strategic misalignment in biopharma

Nearly three out of five biopharma professionals (58%) believe their company’s potential is restricted by rigidity in daily strategic decision-making.  Research commissioned by Nmblr revealed that strategic misalignment is endemic across the industry, threatening both speed to market and the ability to adapt in real-time.  … Read More

#Business & Investment #News

amino acids chain
#Drug development #Drug discovery #Live cell analysis #Protein degradation #Whitepaper

Whitepaper: See what’s driving the next wave of degrader discovery

The kinetic profile of degrader compounds is critical to optimised design, showing how live-cell kinetic analysis transforms discovery. A new Whitepaper from Promega entitled ‘Beyond Endpoints: Capturing and Translating The Dynamics of Targeted Protein Degradation‘ reveals how tracking protein dynamics in live cells delivers richer, more actionable data to… Read More

#News

#Drug development #Drug discovery #Live cell analysis #Protein degradation #Whitepaper

See what’s driving the next wave of degrader discovery

The kinetic profile of degrader compounds is critical to optimised design, showing how live-cell kinetic analysis transforms discovery. This Whitepaper reveals how tracking protein dynamics in live cells delivers richer, more actionable data to improve compound optimisation across programmes. The Whitepaper will discuss: Why kinetic data deliver deeper context than… Read More

#Resources #Whitepapers

#App note #Cell Science #Drug discovery #Life sciences #Live cell analysis #Spheroid

App Note: Go beyond 2D with 3D live-cell technologies

Boost your drug discovery with 3D spheroid models and live-cell analysis – perfect for screening thousands of compounds! A new App Note is now available from Sartorius entitled ‘Enhance Drug Discovery: Utilising a 3D Spheroid Model and Live-Cell Analysis for Compound Profiling’. Download the App Note to learn: How… Read More

#News